Literature DB >> 19944802

Clostridium difficile and inflammatory bowel disease.

Ashwin N Ananthakrishnan1, Mazen Issa, David G Binion.   

Abstract

The past decade has seen an alarming increase in the burden of disease associated with Clostridium difficile. Several studies have now demonstrated an increasing incidence of C difficile infection in patients with inflammatory bowel disease (IBD) with a more severe course of disease compared with the non-IBD population. This article summarizes the available literature on the impact of C difficile infection on IBD and discusses the various diagnostic testing and treatment options available. Also reviewed are clinical situations specific to patients with IBD that are important for the treating physician to recognize.

Entities:  

Year:  2010        PMID: 19944802     DOI: 10.1016/j.mcna.2009.08.013

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  12 in total

1.  Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.

Authors:  David G Binion
Journal:  Gastroenterol Hepatol (N Y)       Date:  2012-09

2.  Preoperative Clostridium difficile infection is not associated with an increased risk for the infection in ileal pouch patients.

Authors:  Chao Sun; Peng Du; Xian-rui Wu; Elaine Queener; Bo Shen
Journal:  Dig Dis Sci       Date:  2014-02-07       Impact factor: 3.199

3.  Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis.

Authors:  Muhammad Ali; Ashwin N Ananthakrishnan; Shahryar Ahmad; Nilay Kumar; Gagan Kumar; Kia Saeian
Journal:  Liver Transpl       Date:  2012-08       Impact factor: 5.799

4.  Management of severe ulcerative colitis.

Authors:  Neeraj Narula; Bindia Jharap; Jean-Frederic Colombel
Journal:  Curr Treat Options Gastroenterol       Date:  2015-03

5.  Clostridium difficile infection and inflammatory bowel disease: understanding the evolving relationship.

Authors:  Udayakumar Navaneethan; Preethi Gk Venkatesh; Bo Shen
Journal:  World J Gastroenterol       Date:  2010-10-21       Impact factor: 5.742

6.  Monocyte human leukocyte antigen-DR expression-a tool to distinguish intestinal bacterial infections from inflammatory bowel disease?

Authors:  Wolfgang Tillinger; Ruth Jilch; Thomas Waldhoer; Walter Reinisch; Wolfgang Junger
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

7.  Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis.

Authors:  V Gupta; R Rodrigues; D Nguyen; J Sauk; H Khalili; V Yajnik; A N Ananthakrishnan
Journal:  Aliment Pharmacol Ther       Date:  2015-11-05       Impact factor: 8.171

8.  Glutamine and alanyl-glutamine increase RhoA expression and reduce Clostridium difficile toxin-a-induced intestinal epithelial cell damage.

Authors:  Ana A Q A Santos; Manuel B Braga-Neto; Marcelo R Oliveira; Rosemeire S Freire; Eduardo B Barros; Thiago M Santiago; Luciana M Rebelo; Claudia Mermelstein; Cirle A Warren; Richard L Guerrant; Gerly A C Brito
Journal:  Biomed Res Int       Date:  2012-12-27       Impact factor: 3.411

Review 9.  The impact of Clostridum difficile on surgical rate among ulcerative colitis patients: A systemic review and meta-analysis.

Authors:  Jiang-Chen Peng; Jun Shen; Qi Zhu; Zhi-Hua Ran
Journal:  Saudi J Gastroenterol       Date:  2015 Jul-Aug       Impact factor: 2.485

Review 10.  An organized approach to imaging of benign cecal pathologies.

Authors:  Ariel Lewis; Shavitri Mahendiran; Jay Hochsztein; Daniel Alterman; Mark Guelfguat
Journal:  BJR Open       Date:  2020-01-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.